Access Bio Statistics

Total Valuation

Access Bio has a market cap or net worth of KRW 203.66 billion. The enterprise value is -171.30 billion.

Market Cap	203.66B
Enterprise Value	-171.30B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Access Bio has 35.17 million shares outstanding. The number of shares has increased by 2.25% in one year.

Current Share Class	n/a
Shares Outstanding	35.17M
Shares Change (YoY)	+2.25%
Shares Change (QoQ)	-1.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.27%
Float	26.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.06
PB Ratio	0.32
P/TBV Ratio	0.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	17.77
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	7.75

Financial Position

The company has a current ratio of 16.45, with a Debt / Equity ratio of 0.10.

Current Ratio	16.45
Quick Ratio	15.33
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-2.89
Interest Coverage	-6.73

Financial Efficiency

Return on equity (ROE) is -1.67% and return on invested capital (ROIC) is -2.02%.

Return on Equity (ROE)	-1.67%
Return on Assets (ROA)	-1.97%
Return on Invested Capital (ROIC)	-2.02%
Return on Capital Employed (ROCE)	-3.26%
Revenue Per Employee	980.79M
Profits Per Employee	-95.42M
Employee Count	101
Asset Turnover	0.14
Inventory Turnover	2.43

Taxes

Income Tax	-1.20B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.06% in the last 52 weeks. The beta is 1.61, so Access Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-13.06%
50-Day Moving Average	5,245.60
200-Day Moving Average	5,715.35
Relative Strength Index (RSI)	53.66
Average Volume (20 Days)	2,053,436

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Access Bio had revenue of KRW 99.06 billion and -9.64 billion in losses. Loss per share was -279.60.

Revenue	99.06B
Gross Profit	40.76B
Operating Income	-22.52B
Pretax Income	-11.67B
Net Income	-9.64B
EBITDA	-2.05B
EBIT	-22.52B
Loss Per Share	-279.60

Full Income Statement

Balance Sheet

The company has 440.91 billion in cash and 63.91 billion in debt, giving a net cash position of 377.00 billion or 10,718.28 per share.

Cash & Cash Equivalents	440.91B
Total Debt	63.91B
Net Cash	377.00B
Net Cash Per Share	10,718.28
Equity (Book Value)	645.49B
Book Value Per Share	18,490.96
Working Capital	452.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.32 billion and capital expenditures -2.77 billion, giving a free cash flow of -22.10 billion.

Operating Cash Flow	-19.32B
Capital Expenditures	-2.77B
Free Cash Flow	-22.10B
FCF Per Share	-628.24

Full Cash Flow Statement

Margins

Gross margin is 41.14%, with operating and profit margins of -22.73% and -9.73%.

Gross Margin	41.14%
Operating Margin	-22.73%
Pretax Margin	-11.78%
Profit Margin	-9.73%
EBITDA Margin	-2.07%
EBIT Margin	-22.73%
FCF Margin	n/a

Dividends & Yields

Access Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.25%
Shareholder Yield	n/a
Earnings Yield	-4.73%
FCF Yield	-10.85%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Access Bio has an Altman Z-Score of 3.78 and a Piotroski F-Score of 2.

Altman Z-Score	3.78
Piotroski F-Score	2